CROI 2018 Abstract eBook

Abstract eBook

Keyword Index

Intimate partner violence 922 Intra-ocular inflammation 797 Intradermal 485 Isoniazid 1113, 37LB, 457 Kaposi sarcoma 133, 654, 655 Kenya 1066, 1067, 1081, 1148, 885LB, 928, 935, 984, 985 Kidney dysfunction 850 Kidney transplantation 728 KwaZulu natal 825 Laboratory-clinical interface 989 Lag3 316 Latency 152LB, 157, 320, 323, 326, 336, 368, 377, 382, 385, 395 Latency reversing agents 72, 321, 324, 330, 331, 382, 395, 454, 1072 Latent class analysis 1132 Latent HIV-1 reservoir 151, 152LB, 153, 156, 158, 322, 328, 338, 344, 375, 379, 388, 389, 390, 394, 397, 399, 658, 69LB Latent profile analysis 152LB, 395, 398, 408 Latin America 1020 Lean mass 733, 738 Ledipasvir/Sofosbuvir 607 LEEP 659 Lesotho 94, 824 Leukocyte-endothelial cell interactions 674 Levonorgestrel 469 Linkage and retention 1077, 1120, 150LB, 887 Linkage to care 1090, 150LB Linkage to care and treatment 1083, 1089, 150LB, 576, 578, 94 Lipid 874 Lipidomics 704 Lipids 737 Lipodystrophy 685 Lipoprotein(a) 672 Liver 266, 639 Liver disease 621, 633, 642, 644, 647 Liver fibrosis 648, 718 Liver transplantation 496, 647 Long non-coding RNA 329 Long-acting 479, 483, 484, 486, 487, 488, 561, 1151 Long-term ART 119 Long-term follow-up 619 Long-term nonprogressor 196, 214 Longitudinal study 77, 122, 436, 672, 1121, 1135, 1138 Lopinavir/ritonavir 508, 741, 781, 838, 841, 842, 878 Loss to follow-up 884 Low-level viremia 461, 517, 574, 990, 1124 LTR 323 Lung function 745, 746, 748, 750, 751 Lungs 242, 367, 745 Lymph node 155, 19, 212, 237, 238, 284, 285, 315, 318, 353LB, 379, 475, 476, 70 Lymphoid tissue 27, 212, 390 Lymphoma 667, 668 M184V 498, 560 Macaque 203, 207, 319LB, 349, 83 Macaque models 82, 215, 256 Machine learning 214, 303, 436, 650, 1018 Macrophage 177, 178, 179, 189, 216, 224LB, 238, 421 Macrophage tropism 373 MACS 400 Magnetic resonance imaging 19, 121, 433 Magnetic resonance spectroscopy 427, 432, 437 Magnetoencephalography 434 Malawi 821 Male circumcision 1064, 1067 Malignancies 75, 651, 652 Malnutrition 839, 849 Lamivudine 474, 489, 498 Large-scale screen 947 Late HIV diagnosis 932 Late presentation 29LB, 826, 932

Maraviroc 258, 342, 482, 483 Mass cytometry 244 Mass spectrometry 475 Mathematical model 147, 344, 507, 660, 1152, 1155 Maturation 185 Maturation inhibitor 173 Medical male circumcision 1065, 1066 Medication 401

Mucosal immunity 249, 256, 264, 274, 367 Mucosal immunology 18, 215, 219, 1055, 1056 Multidrug resistance 511, 561 Multipurpose prevention technology 84 Multistate models 888, 900 Mycobacterium avium complex (MAC) 799 Myeloid activation 252 Myocardial infarction 630, 692 N-terminal prohormone of brain natriuretic peptide 699 NAFLD 642, 643 Nanomedicine 480, 482, 483, 484, 485, 488 Natural killer cells 220, 221, 283, 358 Navigation 1007, 1078 Nef 116, 186, 198, 201, 202, 236, 382 Neopterin 415, 419 Network models 42, 906 NeuroAIDS 120, 406, 407, 410, 411, 436, 447 Neurocognition 401, 411, 420, 855 Neurocognitive disorder 120, 126, 401, 405, 410, 413, 422, 434, 438, 449, 453, 633 Neurocognitive impairment 406, 409, 413, 416, 417, 418, 427, 428, 432, 440, 633, 855 Neurocognitive performance 445, 473 Neurodevelopment 875, 876 Neuroimaging 120, 125, 425, 429, 430, 432, 433, 434, 436, 439, 440, 446 Neuroinflammation 126, 427, 454 Neurotoxicity 418, 425 Neutralization 192, 230 Neutralization response 292, 827 Neutralizing antibodies 113LB, 288, 293 Neutrophils 18, 235, 249, 270, 302 New tests 569, 570 New world prrimate 174 Next generation sequencing (NGS) 175LB, 260, 288, 523, 535, 536, 555 Neuropathogenesis 125, 406, 442, 446, 447 Neuropsychiatric adverse events 402, 424 Neuropsychologic performance 125, 410, 418 Neuropsychology 434, 855

Medication adherence 463, 515, 782 Medication-assisted therapy 181 Memory CD4 T cells 387

Memory cells 282 Men 983, 984, 1122

Men who have sex with men 1009, 1014, 1016, 1019, 1020, 1021, 1023, 1024, 1025, 1026, 1029, 1033, 1034, 1035, 1039, 1040, 1052, 1055, 1101LB, 1146, 1149, 1150, 1151, 149, 168, 255, 263, 264, 265, 40, 44, 347, 463, 519, 585, 590, 591, 592, 612, 613, 626, 662, 663, 87, 88, 905, 906, 911, 912, 914, 916, 929, 945, 946, 957, 958, 968, 978, 979, 980, 982, 994, 995, 997, 999 Meningitis 36, 783 Menopause 1072, 1073, 1074 Menstrual Cycle 207

Mental health 420, 847, 877, 1074 Mental health disorders 752, 943 Metabolism 641, 743, 757 Methamphetamine 519, 760, 968 Mexico 523, 662, 793 MF59 305

MHC tetramers 225 Microarray patch 485 Microbial translocation 18, 239, 252, 253, 254, 257, 261, 272, 313, 682, 867, 882 Microbicides 1056, 1059LB, 1063, 143LB, 144LB, 481, 84 Microbiome 252, 253, 255, 256, 257, 258, 261, 262, 263, 265, 267, 268, 269, 271, 273, 867, 882, 1055, 1057, 1058 Microbiota 268, 275, 708 Microglia 441LB MicroRNA 417, 637, 638, 639, 640

Migrants 853, 931 Migration 945, 954 Milestones 846 Military 705 Military conflict 961 miR-382-5p 197 miRNA 197 Missed visit 753 Mitochondria 280

NK cells 245, 282, 881 NKG2C (KLRC2) 245 Non-AIDS events 517, 763, 765

Non-AIDS malignancy 765 Non-AIDS mortality 763 Noncommunicable diseases 715, 739 Nonhuman primates 167, 351 Nonintegrated DNA 544

Keyword Index

Mitochondrial DNA content 879, 890 Mitochondrial fuel oxidation 757 Mitochondrial injury 760, 878 Mitochondrial toxicity 858 MK-8591 89LB Mobility 755, 766, 936, 1088 Modeling 1117LB, 1146, 1149, 1150, 209, 717 Molecular epidemiology 40, 41, 778, 911, 946, 955 Monitoring 516, 1082, 1130 Monoclonal antibody 561, 1061, 1062, 1063 Monocyte activation 217, 678, 835, 859, 880 Monotherapy 505 Morbidity 490 Mortality 1099, 1110, 1133, 23, 29LB, 38LB, 513, 517, 693, 775, 78, 784, 888, 890, 891, 893, 894, 896, 897, 898, 899, 901, 902, 97, 974 Mortality 891, 895 Mother-to-child transmission 131, 139, 192, 290, 698, 720, 803, 804, 805, 813, 818, 819, 821, 822, 826, 827, 828, 862, 868, 875, 878, 1047, 1147 Mouse model 200, 428 MRI 431, 694, 695 mRNA 311 Mucosal barrier 271, 1056, 1057 Mucosal HIV-1 transmission 249, 271, 319LB

NR1I2 rs2472677 467 NRTI 26, 187, 617, 843 NS5A 582 Nuclear import 187

Nucleic acid test 570, 572 Nurse practitioner 1080 Nutrition status 703 Obesity 735 Occult HBV 615, 616 Ocular complications 797 Omega-3 726 On demand PrEP 1034 Online 1020 Online recruitment 997 Opioid agonist therapy 589 Opioid use 96, 181, 756, 963, 965, 966, 973 Opportunistic infection 768, 785, 787, 792, 793 Option B+ 721, 814, 815, 817, 821, 872, 884, 1071

Organ transplantation 553 Outbreak 779, 952, 967, 973 Outcomes 1122, 1126, 1127 Overdose 891, 974 Oxidative stress 218, 437, 450, 452 p24 172, 383, 393, 567

CROI 2018 481